Error loading player: No playable sources found
FriCU10
Use of PARP Inhibitors for Ovarian Cancer
Date
March 19, 2021
Learning Objectives
- Describe data from PARP inhibitor trials in patients with newly-diagnosed advanced ovarian cancer, and discuss how it may inform treatment and molecular testing in this setting.
- Review factors that may impact the extent of clinical benefit from PARP inhibitor therapy.
- Compare and contrast considerations for selecting recurrence therapy in patients who have progressed/recurred on or after PARPi maintenance.
Speaker
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
General
